Comparing Januvia vs Onglyza
| Januvia (sitagliptin) | Onglyza (saxagliptin) |
|
|---|
| Januvia (sitagliptin) | Onglyza (saxagliptin) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Januvia is a DPP-4 inhibitor that is used in addition to other medications for the treatment of type 2 diabetes. Rarely, it may cause joint pain, skin reactions, pancreatitis, or an allergic... View more |
Prescription only
Prescribed for Type 2 Diabetes. Onglyza may also be used for purposes not listed in this medication guide. |
Related suggestions Type 2 Diabetes
|
|||||||
| More about Januvia (sitagliptin) | More about Onglyza (saxagliptin) | ||||||||
| Ratings & Reviews | |||||||||
|
Januvia has an average rating of 4.5 out of 10 from a total of 139 ratings on Drugs.com. 29% of reviewers reported a positive effect, while 53% reported a negative effect. |
Onglyza has an average rating of 5.9 out of 10 from a total of 15 ratings on Drugs.com. 47% of reviewers reported a positive effect, while 33% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Januvia side effects |
View all Onglyza side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Onglyza prices |
||||||||
| Dosage Forms | |||||||||
|
|
||||||||
| Brand Names | |||||||||
| Other sitagliptin brands include: Brynovin, Zituvio |
N/A |
||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
12.4 hours |
3.1 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 295 drugs are known to interact with Januvia:
|
A total of 414 drugs are known to interact with Onglyza:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
|
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
October 16, 2006 |
July 31, 2009 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.